Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Natalizumab is an effective therapy for multiple sclerosis. Its most notable toxicity is progressive multifocal leukoencephalopathy (PML). The FDA mandated registry, TOUCH, focuses on reporting PML cases. SONAR identified an unusual case of natalizumab associated urethral melanoma and queried FDA databases for all natalizumab associated melanoma events reported to the FDA.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.